NYSE:ART

(ART) (ART) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$4.00
$4.00
52-Week Range
N/A
Volume
34,871 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ART stock logo

About (ART) Stock (NYSE:ART)

Artio Global Investors Inc. (Investors) is an asset management company. Investors provide investment management services to institutional and mutual fund clients. The Company also offers select group of other equity and fixed income strategies, including High Grade Fixed Income, High Yield, International Equity and Global Equity. As of December 31, 2012, the Company managed six different investment strategies across five asset classes: High Grade Fixed Income; High Yield, International Equity, Global Equity,and Emerging Markets Local Debt. The Company’s primary business objective is to consistently generate investment returns for its clients. As of December 31, 2012, its International Equity strategies including High Grade Fixed Income, High Yield, 9International Equity and Global Equity. In May 2013, Aberdeen Asset Management Plc completed the acquisition of Artio Global Investors Inc.

ART Stock News Headlines

The World's First "$20 Trillion Drug?"
One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!
The World's First "$20 Trillion Drug?"
One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!
Is Comedy Really an Art?
See More Headlines
Receive ART Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ART) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

ART Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of (ART) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (ART) investors own include (YOKU) (YOKU), Sarepta Therapeutics (SRPT), Progenics Pharmaceuticals (PGNX), New York Mortgage Trust (NYMT), Nokia Oyj (NOK), (MCPIQ) (MCPIQ), Ivanhoe Energy (IVANF), Finish Line (FINL), Elan (ELN) and Barnes & Noble (BKS).

This page (NYSE:ART) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners